glp-1 zepbound Medicare Coverage for Weight Loss Starts July 2026: What You Need to Know GLP-1 weight-loss drugs: PA, NJ
Description
New research from Sweden has found that GLP-1 agonist drugs used to treat diabetes and obesity are unlikely to increase thyroid cancer risk, as some previous studies had suggested.
Physicians on Sermo share experiences with GLP-1 weight loss drugs and risks
Drugs like semaglutide and liraglutide have recently gained massive attention not just for diabetes, but for weight loss
Are there any semaglutide alternatives that really work
